Evidence map›Paper›PMID 11943762›Full record

ReviewEMBO reports2002

Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes.

Anne Baudry, Loïc Leroux, Malene Jackerott, Rajiv L Joshi

Abstract readReview
In one paragraph

Review in EMBO reports, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Current views on type 2 diabetes.The Journal of endocrinology · 2010
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anne BaudryDepartment of Genetics, Development and Molecular Pathology, Institut Cochin, INSERM, CNRS, Université René Descartes, 24 rue du Faubourg Saint-Jacques, 75014 Paris, France.
Loïc Leroux
Malene Jackerott
Rajiv L Joshi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is a complex heterogeneous polygenic disease characterized mainly by insulin resistance and pancreatic beta-cell dysfunction. In recent years, several genetically engineered mouse models have been developed for the study of the pathophysiological consequences of defined alterations in a single gene or in a set of candidate diabetogenes. These represent new tools that are providing invaluable insights into NIDDM pathogenesis. In this review, we highlight the lessons emerging from the study of some of the transgenic or knockout mice in which the expression of key actors in insulin signaling, action or secretion has been manipulated. In addition to contributing to our knowledge of the specific roles of individual genes in the control of glucose homeostasis, these studies have made it possible to address several crucial issues in NIDDM that have remained controversial or unanswered for a number of years.

Indexed as

Muscle ProteinsAnimalsAnimals, Genetically ModifiedDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2GlucoseGlucose Transporter Type 4InsulinInsulin SecretionIslets of LangerhansMiceMonosaccharide Transport ProteinsPhosphoproteinsPotassium ChannelsSignal TransductionGlucoseGlucose Transporter Type 4InsulinMonosaccharide Transport ProteinsMuscle ProteinsPhosphoproteinsPotassium ChannelsSlc2a4 protein, mouse

Identifiers

PMID11943762
PMCPMC1084066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.